+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05877300

Safety and Feasibility Study of the Cellspan Esophageal Implant for Short Segment Esophageal Reconstruction in Patients Needing Full or Partial Replacement

Led by Harvard Apparatus Regenerative Technology, Inc. · Updated on 2026-09-03

10

Participants Needed

3

Research Sites

73 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and feasibility of the Cellspan Esophageal Implant CEI in patients who need short segment esophageal reconstruction up to 6 cm in length. This first-in-human study involves two groups patients requiring full reconstruction and those who had partial esophagectomy. The study is conducted at up to five centers in the United States, enrolling a total of up to 10 patients. Continuous safety monitoring by an independent committee guides enrollment and risk management. The CEI is a combination product consisting of a synthetic scaffold seeded with the patients own adipose-derived stem cells. For full reconstruction, the implant is surgically placed via thoracotomy, involving esophageal resection, stent placement, and feeding tube insertion. For patients with previous partial esophagectomy, the implant is extended subdermally and connected to the remaining esophagus. Both groups receive stenting and undergo imaging and laboratory tests before and after surgery to monitor implant position and tissue regeneration. Participants will be followed for at least two years after surgery with regular evaluations including CT or MRI scans and endoscopies to assess the formation of a living esophageal conduit and monitor for complications such as leaks, fistulas, or need for emergency surgery. Safety outcomes including mortality within 30 days are tracked. The study involves multiple visits for assessments, imaging, laboratory tests, and monitoring of graft maturation and function throughout the follow-up period.

CONDITIONS

Brief Title

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Research Team

S

Shunfu Hu, Phd.

W

William L Fodor, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here